http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81819c8c559f32b7d547278a300a9e5
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sequist |
| name | Lecia V. Sequist Lecia V Sequist |
| given-name | Lecia V. Lecia V |
| organization-name | All authors: Massachusetts General Hospital, Boston, MA. Massachusetts General Hospital Cancer Center, Boston, MA Lecia V. Sequist, Massachusetts General Hospital and Harvard Medical School, Boston, MA; James Chih-Hsin Yang, National Taiwan University Hospital; Chun-Ming Tsai, Taipei Veterans General Hospital, Taipei; Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan; Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka; Terufumi Kato, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan; Kenneth O'Byrne, St James' Hospital, Dublin, Ireland; Vera Hirsh, McGill University, Montreal, Quebec... Departments of aMedicine, Scott N. Gettinger and Mario Sznol, Yale Cancer Center, New Haven, CT; Leora Horn, David P. Carbone, and Jeffrey A. Sosman, Vanderbilt University Medical Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Leena Gandhi, David M. Jackman, and F. Stephen Hodi, Dana-Farber Cancer Institute; Rebecca S. Heist and Lecia V. Sequist, Massachusetts General Hospital Cancer Center; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Scott J. Antonia and Mary... 2Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 3Department of Medicine, Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital Cancer Center, Dana-Farber/Partners Cancer Care, Harvard Medical School, Boston, MA Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA. Harvard Medical School, Boston, Massachusetts2Massachusetts General Hospital Cancer Center, Boston Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA Massachusetts General Hospital and Harvard Medical School, Boston, MA Massachusetts General Hospital and Harvard Medical School, MGH Cancer Center, 32 Fruit Street, Yawkey 7B, Boston, MA, USA. Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA;; Harvard Medical School, Boston, Massachusetts, USA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA 1Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. From the Massachusetts General Hospital Cancer Center and Dana-Farber Cancer Center, Boston; Wyeth, Cambridge, MA; Institut Gustave Roussy, Villejuif, France; Yale Cancer Center, New Haven, CT; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Southern California, Los Angeles, CA; University of Washington, Seattle, WA. From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; the Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and the Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Massachusetts General Hospital Cancer Center, Boston, MA.; Department of Medicine, Massachusetts General Hospital, Boston, MA. Authors' Affiliations: 1Laboratory of Cellular & Molecular Radiation Oncology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Charlestown; 2Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; and 3Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts; 4Research Oncology, Genentech, Inc., South San Francisco, California; 5Department of Pharmaceutical Biology, Ludwig Maximilian University of Munich, Munich; and 6Center for Oncology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany Zofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, Brandon Nadres, Emily E. Van Seventer, Heather A. Shahzade, Inga T. Lennes, Anthony J. Iafrate, Dora Dias-Santagata, Nicholas A. Jessop, Haichuan Hu, Subba R. Digumarthy, Aaron N. Hata, Ryan B. Corcoran, and Lecia V. Sequist, Massachusetts General Hospital, Boston; Ignaty Leshchiner, Eli and Edythe L. Broad Institute of MIT and Harvard; Susan Moody, Matthew J. Niederst, and Jeffrey A. Engelman, Novartis Institutes for Biomedical Research, Cambridge,... Massachusetts General Hospital Cancer Center Harvard Medical School Boston 55 Fruit Street Boston MA 02114 USA Meghan J. Mooradian, Zofia Piotrowska, Benjamin J. Drapkin, Dora Dias-Santagata, Nicolas Marcoux, Anthony J. Iafrate, Anna F. Farago, Mari Mino-Kenudson, Aaron N. Hata, and Lecia V. Sequist, Massachusetts General Hospital, Boston, MA; Konstantinos Arnaoutakis, University of Arkansas for Medical Sciences, Little Rock, AR; and Rebecca J. Nagy and Richard Lanman, Guardant Health, Redwood City, CA. Authors' Affiliations: 1Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; 2Harvard Medical School; 3Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; 4Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 5Vrije Universiteit, Amsterdam, the Netherlands; 6Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland; and 7Massachusetts General Hospital Cancer Center Boston, Massachusetts; Authors' Affiliations: 1Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; 2Harvard Medical School; 3Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; 4Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 5Vrije Universiteit, Amsterdam, the Netherlands; 6Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland; and 7Massachusetts General Hospital Cancer Center Boston, Massachusetts Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Authors' Affiliation: Massachusetts General Hospital Cancer Center, Boston, Massachusetts Department of Hematology Oncology Massachusetts General Hospital Boston Massachusetts 3Medicine and; 5Medicine and; 7Massachusetts General Hospital Cancer Center; Departments of Massachusetts General Hospital Cancer Center, Harvard Medical School/Partners HealthCare Center for Genetics and Genomics, Massachusetts General Hospital Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts,USA Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA. lvsequist@partners.org 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston James Chih-Hsin Yang and Chia-Chi Lin, National Taiwan University Hospital, Taipei; Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China; Myung-Ju Ahn, Sungkyunkwan University; Dong-Wan Kim, Seoul National University Hospital; Sang-We Kim, Asan Medical Center, Seoul; Joo-Hang Kim, CHA University, Gyeonggi-do, Republic of Korea; Suresh S. Ramalingam, Emory University School of Medicine, Atlanta, GA; Lecia V. Sequist, Massachusetts General Hospital; Pasi A. Jänne, Dana... Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA National Taiwan University Hospital, Taipei, Taiwan; and Massachusetts General Hospital-Harvard Medical School, Boston, MA Authors' Affiliations: 1Pathology and 2Radiology, Massachusetts General Hospital, Boston; 3Massachusetts General Hospital Cancer Center, Boston; 4Department of Medicine, Harvard Medical School, Boston; 5Radiation Oncology, Steele Lab for Tumor Biology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts; 6Department of Medicine, 7Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; 8Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú; Authors' Affiliations: 1Pathology and 2Radiology, Massachusetts General Hospital, Boston; 3Massachusetts General Hospital Cancer Center, Boston; 4Department of Medicine, Harvard Medical School, Boston; 5Radiation Oncology, Steele Lab for Tumor Biology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts; 6Department of Medicine, 7Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; 8Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú James Chih-Hsin Yang, National Taiwan University Hospital, Taipei, Taiwan; Vera Hirsh, McGill University, Montreal, Quebec, Canada; Martin Schuler, West German Cancer Center, University Duisburg-Essen, Essen; Juliane Lungershausen, Boehringer Ingelheim GmbH, Ingelheim, Germany; Nobuyuki Yamamoto, Shizuoka Cancer Center, Shizuoka, Japan; Kenneth J. O'Byrne, St James' Hospital, Dublin, Ireland; Tony S.K. Mok, State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong... Massachusetts General Hospital Cancer Center; Harvard Medical School; Boston; USA; Department of Medicine Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Massachusetts General Hospital, Boston Anna F. Farago, Zofia Piotrowska, and Lecia V. Sequist, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA Department of Medicine Massachusetts General Hospital & Harvard Medical School Boston Massachusetts From the Massachusetts General Hospital Cancer Center; Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital; Department of Pathology, Massachusetts General Hospital; Department of Biostatistics, Massachusetts General Hospital, Boston; Harvard Medical School/Partners Health Care Center for Genetics and Genomics, Cambridge, MA; University of Washington, Seattle, WA; Sarah Cannon Research Institute, Nashville, TN; Fletcher Allen Health Care, Burlington, VT; Fairfax-Northern... Department of Medicine and Massachusetts General Hospital Cancer Center, Harvard Medical, School, Boston, MA, USA. Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA Authors' Affiliation: Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.; Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA. Lucia Nogova, Reinhard Buettner, and Jürgen Wolf, University Hospital Cologne, Cologne; Martin Schuler, University Hospital Essen, and German Cancer Consortium (DKTK), Essen, Germany; Lecia V. Sequist, Massachusetts General Hospital; Geoffrey I. Shapiro, Dana-Farber Cancer Institute, Boston, MA; Jose Manuel Perez Garcia, Vall d'Hebron Institut d’Oncologia, Barcelona; Manuel Hidalgo, START Madrid; Manuel Hidalgo, Spanish National Cancer Research Centre, Madrid, Spain; Fabrice Andre, Gustave Roussy,... Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Giorgio Scagliotti and Silvia Novello, University of Turin, Orbassano, Torino; Adolfo Favaretto, Istituto Oncologico Veneto, Padova; Armando Santoro, Istituto Clinico Humanitas, Milan, Italy; Joachim von Pawel, Asklepios-Fachkliniken München-Gauting, Munich, Germany; Rodryg Ramlau, Poznań University of Medical Sciences, Poznań, Poland; Fabrice Barlesi, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France; Wallace Akerley, Huntsman Cancer Institute, Salt Lake City, UT;... Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114;; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; and 1Division of Hematology/Oncology, Massachusetts General Hospital; Cancer Center, Massachusetts General Hospital, Boston, MA Massachusettes General Hospital Boston Massachusetts Authors' Affiliations: 1Vanderbilt-Ingram Cancer Center, the Department of Medicine/Division of Hematology-Oncology, 2Department of Biostatistics/Division of Cancer Biostatistics, 3Center for Quantitative Science, Vanderbilt University School of Medicine; 4Departments of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; 5Department of Pathology, 6Massachusetts General Hospital Cancer Center; 7Harvard Medical School, Boston, Massachusetts; 8Department of Pathology, 9Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 10Johns Hopkins University, Baltimore, Maryland; 11Catalan Institute of Oncology, Universitat Autonoma de Barcelona and Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; 12University of Colorado Cancer Center, Aurora, Colorado; 13Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan; 14Translational Oncology Research L; Authors' Affiliations: 1Vanderbilt-Ingram Cancer Center, the Department of Medicine/Division of Hematology-Oncology, 2Department of Biostatistics/Division of Cancer Biostatistics, 3Center for Quantitative Science, Vanderbilt University School of Medicine; 4Departments of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee; 5Department of Pathology, 6Massachusetts General Hospital Cancer Center; 7Harvard Medical School, Boston, Massachusetts; 8Department of Pathology, 9Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York; 10Johns Hopkins University, Baltimore, Maryland; 11Catalan Institute of Oncology, Universitat Autonoma de Barcelona and Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; 12University of Colorado Cancer Center, Aurora, Colorado; 13Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan; 14Translational Oncology Research L Martin J. Edelman, Josephine Feliciano, Yang Yang, and Michelle Medeiros, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Ming T. Tan, Georgetown University, Washington, DC; Mary J. Fidler, Rush University Medical Center, Chicago, IL; Rachel E. Sanborn, Providence Portland Medical Center, Portland, OR; Greg Otterson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Lecia V. Sequist, Massachusetts General Hospital Cancer Center, Boston, MA; Tracey L. Evans, University... 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 3Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology, 3Lowe Center for Thoracic Oncology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; 5Massachusetts General Hospital Cancer Center; 6Harvard Medical School; 7Department of Pathology, Harvard Medical School; 8Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston; and 9Broad Institute of Harvard and MIT, Cambridge, Massachusetts Massachusetts General Hospital, Boston, Massachusetts, USA 4Massachusetts General Hospital, Boston, Massachusetts. Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, 2Center for Bioengineering in Medicine and Departments of 3Radiation Oncology, 4Medicine, 5Surgery and 6Pathology, Harvard Medical School, Charlestown, Massachusetts; 7Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York; and 8Howard Hughes Medical Institute, Chevy Chase, Maryland; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, 2Center for Bioengineering in Medicine and Departments of 3Radiation Oncology, 4Medicine, 5Surgery and 6Pathology, Harvard Medical School, Charlestown, Massachusetts; 7Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York; and 8Howard Hughes Medical Institute, Chevy Chase, Maryland Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and 1Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Massachusetts General Hospital Cancer Center Boston Massachusetts 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 5Harvard Medical School, Boston, Massachusetts.; 8Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Massachusetts General Hospital, Boston, MA From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;; Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Massachusetts General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. Authors' Affiliations: 1University of Pittsburgh Cancer Institute, Pittsburgh; 2Penn State Hershey Cancer Institute, Hershey, Pennsylvania; 3Premiere Oncology, Santa Monica; 4City of Hope, Duarte, California; 5Synta Pharmaceuticals Corp., Lexington; 6Massachusetts General Hospital; 7Beth Israel Deaconess Medical Center; 8Dana-Farber Cancer Institute, Boston, Massachusetts; 9Vanderbilt Ingram Cancer Center, Nashville, Tennessee; 10Piedmont Hematology Oncology Associates, Winston-Salem, North Carolina; 11University of Chicago Medical Center; 12Rush University Medical Center, Chicago, Illinois; 13Swedish Cancer Center, Seattle, Washington; 14Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; 15Nevada Cancer Institute, Las Vegas, Nevada; 16OHSU, Knight Cancer Institute, Portland, Oregon; 17Genesis Cancer Center, Hot Springs, Arkansas; 18Hackensack University Medical Center, Hackensack, New Jersey; and 19Winship Cancer Institute, Emory University, Atlanta, Georgia Jonathan W. Goldman, University of California Los Angeles; Ronald B. Natale, Cedars-Sinai Medical Center, Los Angeles; Vlada Melnikova, Aleksandra Franovic, and Mark Erlander, Trovagene, San Diego; Karen Reckamp, City of Hope Comprehensive Cancer Center, Duarte; Sai-Hong Ignatius Ou, University of California Irvine School of Medicine, Orange; Joel W. Neal and Heather A. Wakelee, Stanford University, Stanford, CA; Chris Karlovich, Darrin Despain, Sergey Yurasov, Jason B. Litten, and Mitch Raponi, Clovis... Massachusetts General Hospital, Boston, Masschusetts. 1Cancer Center and Departments of; 2Medicine and From the Massachusetts General Hospital Cancer Center; Harvard Medical School; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston; Infinity Pharmaceuticals, Inc, Cambridge, MA; Yale University School of Medicine and Yale Cancer Center, New Haven, CT; Mary Crowley Cancer Research Center, Dallas, TX; University of Washington, Seattle, WA; Mt Sinai Cancer Center, Miami Beach; Moffitt Cancer Center, Tampa, FL; and Cedars-Sinai Medical Center, Los Angeles, CA. Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 7Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston Massachusetts General Hospital Cancer Center, Department of Medicine and Harvard Medical School, Boston, MA 02114, USA. Department of Medicine, Massachusetts General Hospital, Boston, MA Authors' Affiliations: 1Harvard Medical School; 2Massachusetts General Hospital Cancer Center; and 3Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts; Authors' Affiliations: 1Harvard Medical School; 2Massachusetts General Hospital Cancer Center; and 3Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts Massachusetts General Hospital Cancer Center, Boston, MA 02114;; Departments of cMedicine and Ibiayi Dagogo-Jack, Lorin A. Ferris, Jessica J. Lin, Katherine R. Schultz, Jennifer Ackil, Sara Stevens, Leila Dardaei, Satoshi Yoda, Harper Hubbeling, Subba R. Digumarthy, Aaron N. Hata, Lecia V. Sequist, Inga T. Lennes, Anthony John Iafrate, Rebecca S. Heist, Christopher G. Azzoli, Anna F. Farago, Jochen K. Lennerz, Cyril H. Benes, Alice T. Shaw, and Justin F. Gainor, Massachusetts General Hospital, Boston; and A. Rose Brannon, Catarina D. Campbell, Markus Riester, Jeffrey A. Engelman, and Rebecca J.... Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114;; Division of Hematology–Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; 1Massachusetts General Hospital, Boston, Massachusetts.; 4Harvard Medical School, Boston, Massachusetts. 2Massachusetts General Hospital, and 1Massachusetts General Hospital; Lecia V. Sequist, Massachusetts General Hospital Cancer Center and Harvard Medical School; Daniel B. Costa, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; Edward G. Garmey, Dora Ferrari, Yinpu Chen, Brian Schwartz, ArQule, Woburn, MA; Joachim von Pawel, Asklepios Fachkliniken, München-Gauting; Wolfram Brugger, Schwarzwald-Baar Clinic, Academic Teaching Hospital, University of Freiburg, Villingen-Schwenningen, Germany; Wallace L. Akerley, Huntsman Cancer Institute, Salt Lake City... Scott Gettinger, Yale Cancer Center, New Haven, CT; Leora Horn, Vanderbilt University Medical Center; David Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; David Jackman, Dana-Farber Cancer Institute; Rebecca Heist and Lecia V. Sequist, Massachusetts General Hospital, Boston, MA; Scott Antonia, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Matthew Hellmann, Memorial Sloan-Kettering Cancer Center, New York, NY; John Powderly, Carolina BioOncology Institute,... d Center for Thoracic Cancers, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA; f Harvard Medical School, Boston, Massachusetts, USA Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA |
Incoming Links
Total number of triples: 332.